News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,024 Results
Type
Article (6913)
Company Profile (25)
Press Release (264086)
Section
Business (94074)
Career Advice (561)
Deals (17782)
Drug Delivery (13)
Drug Development (23792)
Employer Resources (40)
FDA (4723)
Job Trends (5182)
News (142000)
Policy (10493)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (2)
Academia (402)
Accelerated approval (2)
Adcomms (3)
Allergies (16)
Alliances (18202)
ALS (23)
Alzheimer's disease (343)
Antibody-drug conjugate (ADC) (18)
Approvals (4750)
Artificial intelligence (79)
Autoimmune disease (5)
Automation (5)
Bankruptcy (130)
Best Places to Work (3943)
BIOSECURE Act (3)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (17)
Brain cancer (8)
Breast cancer (89)
Cancer (622)
Cardiovascular disease (31)
Career advice (475)
Career pathing (4)
CAR-T (33)
Cell therapy (120)
Cervical cancer (3)
Clinical research (19982)
Collaboration (241)
Compensation (174)
Complete response letters (5)
COVID-19 (533)
CRISPR (7)
C-suite (117)
Cystic fibrosis (30)
Data (662)
Depression (7)
Diabetes (61)
Diagnostics (2529)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (32)
Drug pricing (11)
Drug shortages (2)
Duchenne muscular dystrophy (12)
Earnings (44786)
Editorial (2)
Employer branding (6)
Employer resources (39)
Events (43214)
Executive appointments (370)
FDA (5063)
Featured Employer (8)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (241)
Gene editing (18)
Generative AI (4)
Gene therapy (68)
GLP-1 (159)
Government (748)
Grass and pollen (2)
Guidances (21)
Healthcare (6291)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (7)
Infectious disease (553)
Inflammatory bowel disease (28)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (19)
Interviews (68)
IPO (9079)
IRA (4)
Job creations (1354)
Job search strategy (428)
Kidney cancer (8)
Labor market (6)
Layoffs (122)
Leadership (7)
Legal (3051)
Liver cancer (19)
Lung cancer (80)
Lymphoma (37)
Management (16)
Manufacturing (78)
MASH (29)
Medical device (5081)
Medtech (5084)
Mergers & acquisitions (9009)
Metabolic disorders (151)
Multiple sclerosis (23)
NASH (6)
Neurodegenerative disease (14)
Neuropsychiatric disorders (2)
Neuroscience (471)
NextGen: Class of 2025 (2163)
Non-profit (899)
Northern California (1040)
Now hiring (9)
Obesity (61)
Opinion (46)
Ovarian cancer (19)
Pain (20)
Pancreatic cancer (20)
Parkinson's disease (30)
Partnered (12)
Patents (38)
Patient recruitment (32)
Peanut (6)
People (28361)
Pharmaceutical (9)
Pharmacy benefit managers (1)
Phase I (5822)
Phase II (8817)
Phase III (6929)
Pipeline (622)
Policy (16)
Postmarket research (748)
Preclinical (2276)
Press Release (67)
Prostate cancer (32)
Psychedelics (5)
Radiopharmaceuticals (126)
Rare diseases (94)
Real estate (2275)
Recruiting (12)
Regulatory (7226)
Reports (16)
Research institute (421)
Resumes & cover letters (83)
Rett syndrome (3)
RSV (1)
Schizophrenia (29)
Series A (31)
Series B (23)
Service/supplier (2)
Sickle cell disease (10)
Southern California (815)
Special edition (1)
Spinal muscular atrophy (36)
Sponsored (13)
Startups (1197)
State (1)
Stomach cancer (2)
Supply chain (18)
Tariffs (5)
United States (8577)
Vaccines (99)
Venture capitalists (4)
Weight loss (25)
Women's health (3)
Worklife (1)
Date
Last 7 days (225)
Last 30 days (839)
Last 365 days (12692)
2025 (3822)
2024 (13899)
2023 (16175)
2022 (22160)
2021 (23818)
2020 (21942)
2019 (16672)
2018 (12774)
2017 (12262)
2016 (11254)
2015 (14528)
2014 (11365)
2013 (9263)
2012 (10043)
2011 (10447)
2010 (10047)
Location
Africa (228)
Alabama (16)
Alaska (3)
Arizona (73)
Arkansas (1)
Asia (13960)
Australia (1886)
California (2239)
Canada (1161)
China (102)
Colorado (103)
Connecticut (100)
Delaware (42)
Europe (29138)
Florida (342)
Georgia (57)
Idaho (29)
Illinois (145)
India (7)
Indiana (118)
Iowa (2)
Japan (85)
Kansas (34)
Kentucky (11)
Louisiana (5)
Maine (43)
Maryland (278)
Massachusetts (1704)
Michigan (114)
Minnesota (158)
Mississippi (1)
Missouri (25)
Montana (16)
Nebraska (14)
Nevada (30)
New Hampshire (24)
New Jersey (769)
New Mexico (12)
New York (647)
North Carolina (394)
North Dakota (2)
Northern California (1040)
Ohio (78)
Oklahoma (7)
Oregon (4)
Pennsylvania (427)
Puerto Rico (5)
Rhode Island (14)
South America (364)
South Carolina (5)
Southern California (815)
Tennessee (47)
Texas (347)
Utah (65)
Virginia (56)
Washington D.C. (13)
Washington State (187)
West Virginia (2)
Wisconsin (35)
271,024 Results for "sharps compliance corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
·
3 min read
Press Releases
Sharp Therapeutics Corp. Completes Share Consolidation
January 27, 2025
·
3 min read
Press Releases
Sharp Therapeutics Corp. Announces Share Consolidation
January 16, 2025
·
4 min read
Press Releases
Sharp Therapeutics Corp. Announces Completion of Qualifying Transaction
December 12, 2024
·
9 min read
Press Releases
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
December 12, 2024
·
8 min read
Press Releases
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
January 28, 2025
·
6 min read
Press Releases
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
April 9, 2025
·
2 min read
Press Releases
180 Life Sciences Corp. Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Rule and Expands into the Global iGaming Sector
October 9, 2024
·
11 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Deals
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - June 26, 2024
Tonix Pharmaceuticals Holding Corp. today announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
June 26, 2024
·
4 min read
1 of 27,103
Next
